Zetsche, Bernd
Heidenreich, Matthias
Mohanraju, Prarthana
Fedorova, Iana
Kneppers, Jeroen
DeGennaro, Ellen M https://orcid.org/0000-0001-5506-6451
Winblad, Nerges
Choudhury, Sourav R
Abudayyeh, Omar O
Gootenberg, Jonathan S
Wu, Wen Y
Scott, David A
Severinov, Konstantin
van der Oost, John
Zhang, Feng
Article History
Received: 4 March 2016
Accepted: 3 November 2016
First Online: 5 December 2016
Change Date: 12 January 2017
Change Type: Erratum
Change Details: In the version of this article initially published, in Fig. 2j, the percentage for the targets Mecp2, Nlgn3, and Drd1 should be 15.2%, not 16.9%; the same error appeared in the main text, next to last paragraph, “Our results show that ~17%...” should be “Our results show that ~15%....” In the Fig. 2 legend, KASH should be spelled out as “KASH, Klarsicht ANC1 Syne1 homology...” (not “KASH ANC1, Syne homology...”). The errors have been corrected in the HTML and PDF versions of the article.
Competing interests
: A patent has been filed relating to the presented data. F.Z. is a founder and scientific advisor for Editas Medicine, and a scientific advisor for Horizon Discovery.